An immunohistochemical study of cyclooxygenase-2 expression in canine multicentric lymphoma

Cyclooxygenase-2 (COX-2) expression has been associated with development and progression in spontaneous human and dogs tumors. Studies demonstrated that non-steroidal anti-inflammatory drugs, which inhibit COX enzyme, may be used in the treatment of some tumors. Lymphoma is a systemic disease and th...

Descripción completa

Detalles Bibliográficos
Autores: Rodrigues, L.C.S., Cogliati, B., Guerra, J.L, Dagli, M.L.Z., Lucas, S.R.R.
Tipo de recurso: artículo
Fecha de publicación:2011
País:España
Institución:Universidad de Murcia
Repositorio:DIGITUM. Depósito Digital Institucional de la Universidad de Murcia
OAI Identifier:oai:digitum.um.es:10201/28842
Acceso en línea:http://hdl.handle.net/10201/28842
Access Level:acceso abierto
Palabra clave:Cancer
Dog
636 - Veterinaria. Explotación y cría de animales. Cría del ganado y de animales domésticos
Descripción
Sumario:Cyclooxygenase-2 (COX-2) expression has been associated with development and progression in spontaneous human and dogs tumors. Studies demonstrated that non-steroidal anti-inflammatory drugs, which inhibit COX enzyme, may be used in the treatment of some tumors. Lymphoma is a systemic disease and the most common hematological malignancy in dogs. There are few studies about COX-2 expression in human and canine lymphoma. In this study, immunohistochemical evaluation for COX-2 expression was performed in 12 dogs with multicentric lymphoma. The diagnosis was confirmed by histopathological examination. Six samples of normal lymph nodes were either used in the study. No COX-2 immunoreactivity was detected in all samples from canine lymphoma and normal lymph nodes, as well previous studies in canine lymphoma.